From my understanding, yes, CF33 trial must come first. At the very least, it must be shown to be safe and tolerable. I believe the company is pretty confident of achieving that just like how they have shown the B-cell platform to be safe and tolerable. That is probably why they schedule the combo trial to start early 2022.
- Forums
- ASX - By Stock
- IMU
- Ann: Investor Presentation
Ann: Investor Presentation, page-13
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $416.4M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.5¢ | $923.6K | 16.70M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
38 | 4324614 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 3113463 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 4324614 | 0.054 |
22 | 3817830 | 0.053 |
35 | 5615981 | 0.052 |
35 | 3850861 | 0.051 |
71 | 6808215 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 3113463 | 18 |
0.057 | 5729649 | 11 |
0.058 | 953278 | 6 |
0.059 | 678000 | 6 |
0.060 | 1800948 | 8 |
Last trade - 12.55pm 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |